FDA for the second consecutive day, and for the second time in 20 months about cannabidiol products, on Nov. 1 announced warnings to dietary supplement firms that investigational new drug studies of an ingredient precludes its use in dietary supplements.
The agency published warnings to four firms marketing supplements containing CDB ingredients with claims to treat or cure cancer made...




